Presentation ESC 2025 Helicobacter Pylori Screening after Acute Myocardial Infarction: The Cluster Randomized Crossover HELP-MI-SWEDEHEART Trial Presenter: Robin Hofmann August 31, 2025 REGISTER for free or LOG IN to view this content Clinical Cardiology Clinical Pharma Coronary CAD Pharma ACS/AMI Presentation ESC 2025 Up Next Presentation ESC 2025 DAPA ACT HF – TIMI 68: Dapagliflozin in Patients Hospitalized for Heart Failure Presenter: David D. Berg August 30, 2025 More slides + Presentation ESC 2025 SWEDEPAD 1 and 2: Impact of drug-coated devices in patients with peripheral arterial disease Presenter: Mårten Falkenberg August 31, 2025 Presentation ESC 2025 Tailored Antiplatelet Therapy in High-Risk Patients Undergoing Complex PCI: The TAILORED-CHIP Randomized Clinical Trial Presenter: Duk-Woo Park August 31, 2025 We Recommend
Presentation ESC 2025 DAPA ACT HF – TIMI 68: Dapagliflozin in Patients Hospitalized for Heart Failure Presenter: David D. Berg August 30, 2025
Presentation ESC 2025 SWEDEPAD 1 and 2: Impact of drug-coated devices in patients with peripheral arterial disease Presenter: Mårten Falkenberg August 31, 2025
Presentation ESC 2025 Tailored Antiplatelet Therapy in High-Risk Patients Undergoing Complex PCI: The TAILORED-CHIP Randomized Clinical Trial Presenter: Duk-Woo Park August 31, 2025